Can Colloidal Silver Effectively Combat Rare Pathogens Despite Its Risks?

  • Context: Medical 
  • Thread starter Thread starter Aero51
  • Start date Start date
  • Tags Tags
    Silver
Click For Summary
SUMMARY

Colloidal silver has demonstrated the ability to kill approximately 600 types of bacteria and viruses in vitro, but its use poses significant risks, including argyria and kidney damage, particularly with high consumption. Despite its potential benefits, there is a lack of in vivo studies, especially regarding its efficacy against rare pathogens like flesh-eating bacteria and HIV. The absence of clinical testing may stem from concerns over the toxic effects of silver as a heavy metal. Current applications include its use against MRSA and in contaminated wounds, but further research is necessary.

PREREQUISITES
  • Understanding of colloidal silver properties and applications
  • Knowledge of argyria and its implications
  • Familiarity with in vitro vs. in vivo study methodologies
  • Awareness of MRSA and its treatment options
NEXT STEPS
  • Research the mechanisms of action of colloidal silver against pathogens
  • Investigate the clinical implications of argyria and kidney damage
  • Explore existing studies on colloidal silver's effectiveness against MRSA and HIV
  • Review guidelines for safe usage of colloidal silver in medical applications
USEFUL FOR

This discussion is beneficial for medical researchers, healthcare professionals, and individuals interested in alternative treatments for infections, particularly those exploring the use of colloidal silver in combating rare pathogens.

Aero51
Messages
545
Reaction score
10
Good evening, I just have a quick question regarding the potential uses of colloidal silver as a cure for many types of pathogens. It is my understanding that colloidal silver can kill about 600 different types of bacteria/viruses based on many in-vitro studies. Despite its potential benefits, colloidal silver can cause argyria and kidney damage if it is not totally flushed out of the body. Cases of argyria and kidney damage as a result of colloidal silver intake tend to not occur unless a significant quantity is consumed. Obviously, CS should not be used on a regular basis.

This leads me to the point of this thread: How come colloidal silver has not been tested for use in cases where people acquire rare and potent diseases, such as flesh eating bacteria or HIV? It seems like having your skin turn blue is a small price to pay for preventing an amputation or death.

Here are some resources I used:
http://videos.howstuffworks.com/discovery/30564-one-step-beyond-argyria-video.htm
http://en.wikipedia.org/wiki/Medical_uses_of_silver
 
Last edited by a moderator:
Biology news on Phys.org
Maybe the fact that silver being a heavy metal leading toxic effects damaging liver and kidney enough to prevent marketing such product
 
The problem is that virtually no studies have been conducted in-vivo, even on mice. Its a shame that these avenues of medicine are not being explored. Even if a potential antidote is proven to be a failure, at least someone tried.
 
Last edited by a moderator:

Similar threads

Replies
1
Views
6K